THURSDAY, DECEMBER 14, 2017

Social marketing campaign successful in HIV prevention

The District of Columbia Department of Health (DOH) released a report on Monday that showed its social marketing campaign to prevent HIV in DC has been successful. Read More »

Cause of TB, smoking link discovered

Smoking is the biggest driver of the worldwide tuberculosis epidemic, and scientists at Trinity College Dublin and St James's Hospital in Ireland have figured out why. Read More »

Electron microscopy advances uncover weaknesses in HIV and other viruses

Researchers at the University of California-Davis have made advances in the science of electron microscopy that have allowed them to detect weaknesses in HIV and other viruses. Read More »

Novavax clinical trial to evaluate new flu vaccine

Novavax, Inc., has announced that patient enrollment has begun in its Phase 2 clinical trial of its new recombinant quadrivalent seasonal influenza virus-like particle vaccine, entitled Seasonal Influenza VLP. Read More »

Meningococcal Group B vaccine is now FDA-approved and available

In a recent announcement, Pfizer Inc. confirmed that its Meningococcal Group B Vaccine, TRUMENBA® has been approved by the FDA and is now available to US health professionals for active vaccination. Read More »

THERAVECTYS releases lentiviral vaccine trial data

THERAVECTUS, a biotechnology company specializing in discovering and developing therapeutic vaccines, recently released its latest, encouraging findings from its Phase I and II lentiviral vector-based vaccine study. Read More »

Survey: Americans not aware of how to prevent flu

Many adults aren’t aware of protective measures in place to fight influenza, Families Fighting Flu found in a recent survey. Read More »

Researchers show some types of avian flu more serious than others

Certain types of the avian flu can cause more severe disease in humans than other subtypes of the avian flu and should be watched carefully to prevent spread of disease. Read More »

Scientists create molecular cage to improve vaccines

Biochemists from UCLA recently developed a protein that changes itself into a “cage” of molecules, which holds promise for creating synthetic vaccines for the flu and HIV, among other illnesses. Read More »

International scientists discussing Ebola cure from plasma

Scientists from Africa, Asia Europe, and the United States have united in the Global Emerging Pathogens Therapy/Treatment (GET) forum to discuss the possibility of implementing plasma treatments to cure Ebola. Read More »

IDRI secures massive contract to create process to freeze-dry TB vaccine

A vaccine can be developed and used, but if it gets damaged during transport, “it does no good.” Read More »

UNAIDS has fast-track plan to end AIDS epidemic by 2030

By taking a fast-track approach in the battle against AIDS over the next five years, the Joint United Nations Programme on HIV/AIDS (UNAIDS) said on Tuesday that it hopes 21 million lives will be saved. Read More »

New tool detects beginning of flu season

Researchers from the University of Massachusetts at Amherst and Johns Hopkins have developed a new method to determine the onset of influenza season, which will help health care workers deliver more accurate treatments and prevent spread of the flu. Read More »

Study suggests artificially mutating flu strains may lead to better vaccines

Scientists believe the best way to strengthen flu vaccines is to evolve the influenza virus pre-emptively in the safety of their labs. Read More »

French scientists unlock clearer picture of flu virus machine

Scientists at the European Molecular Biology Laboratory in Grenoble, France, may now better understand the flu virus after obtaining the first complete structure of one of the virus' key machines. Read More »

Gates Foundation pledges $5.7 million to fight Ebola epidemic

The Bill & Melinda Gates Foundation has pledged $5.7 million to support efforts in Guinea and other Ebola-affected countries to increase the production and evaluation of convalescent plasma and other blood products as possible treatments for the virus. Read More »

Miles to End Polio raises more than $1 million to help end the crippling disease

As part of the Miles to End Polio campaign, Rotary General Secretary John Hewko and six Rotary International staff members raised more than $1 million for this year's El Tour de Tucson bike ride. Read More »

New vaccine strategy has potential to prevent birth defects

A new City of Hope study has produced results for a strategy that can potentially prevent a viral infection that causes 5000 babies a year to be born with permanent disabilities. Read More »

New study claims HIV/AIDS medications could also treat AMD

A recent study suggests that HIV/AIDS drugs that have been used for the last 30 years could also be used to treat the dry form of age-related macular degeneration (AMD), as well as other inflammatory disorders. Read More »

UC-Riverside study finds yellow fever replicates in the liver

A team of researchers at the University of California – Riverside recently determined that the yellow fever virus replicates primarily in the liver and other organ failures that often follow are due to secondary effects. Read More »